Sales decline 30.83% to Rs 17.43 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 0.33 crore in the quarter ended December 2021 as against net loss of Rs 1.89 crore during the previous quarter ended December 2020. Sales declined 30.83% to Rs 17.43 crore in the quarter ended December 2021 as against Rs 25.20 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales17.4325.20 -31 OPM %5.85-8.97 -PBDT-0.40-2.36 83 PBT-0.44-2.42 82 NP-0.33-1.89 83Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
